ArticleJournal of comparative effectiveness research2023
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.
Francisco Marín et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.